Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
La Revue Du Praticien
|
February 6, 2019
Breast cancer diagnostic assessment
Florence Dalenc, Elvire Pons, Henri Roche
Bulletin Du Cancer
|
May 23, 2013
[Anticancer drug adherence]
Fabien Despas, Henri Roche, Guy Laurent
Cancer
|
May 27, 2010
Systemic therapy of inflammatory breast cancer from high-dose chemotherapy to targeted therapies: the French experience
Patrice Viens, Carole Tarpin, Henri Roche, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
February 25, 2003
High-dose chemotherapy for breast cancer: the French PEGASE experience
Henri Roche, Patrice Viens, Pierre Biron, et al.
Breast Cancer Research and Treatment
|
November 10, 2010
Economic issues involved in integrating genomic testing into clinical care: the case of genomic testing to guide decision-making about chemotherapy for breast cancer patients
Patricia Marino, Carole Siani, François Bertucci, et al.
Oncology
|
January 12, 2008
A phase I dose-escalating and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer
Jean Pierre Delord, Florence Dalenc, Frédéric Pinguet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2008
Estrogen receptor expression and efficacy of docetaxel-containing adjuvant chemotherapy in patients with node-positive breast cancer: results from a pooled analysis
Fabrice Andre, Kristine Broglio, Henri Roche, et al.
Clinical Breast Cancer
|
August 30, 2018
Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical Trials
Hope S Rugo, Henri Roche, Eva Thomas, et al.
Cancer
|
October 21, 2006
Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial
Corinne Veyret, Christelle Levy, Philippe Chollet, et al.
Oncology
|
December 5, 2014
Neurotoxicity as a prognostic factor in patients with metastatic breast cancer treated with ixabepilone as a first-line therapy
Xavier Durando, Florence Dalenc, Catherine Abrial, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
La Revue Du Praticien
|
February 6, 2019
Breast cancer diagnostic assessment
Florence Dalenc, Elvire Pons, Henri Roche
Bulletin Du Cancer
|
May 23, 2013
[Anticancer drug adherence]
Fabien Despas, Henri Roche, Guy Laurent
Cancer
|
May 27, 2010
Systemic therapy of inflammatory breast cancer from high-dose chemotherapy to targeted therapies: the French experience
Patrice Viens, Carole Tarpin, Henri Roche, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
February 25, 2003
High-dose chemotherapy for breast cancer: the French PEGASE experience
Henri Roche, Patrice Viens, Pierre Biron, et al.
Breast Cancer Research and Treatment
|
November 10, 2010
Economic issues involved in integrating genomic testing into clinical care: the case of genomic testing to guide decision-making about chemotherapy for breast cancer patients
Patricia Marino, Carole Siani, François Bertucci, et al.
Oncology
|
January 12, 2008
A phase I dose-escalating and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer
Jean Pierre Delord, Florence Dalenc, Frédéric Pinguet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2008
Estrogen receptor expression and efficacy of docetaxel-containing adjuvant chemotherapy in patients with node-positive breast cancer: results from a pooled analysis
Fabrice Andre, Kristine Broglio, Henri Roche, et al.
Clinical Breast Cancer
|
August 30, 2018
Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical Trials
Hope S Rugo, Henri Roche, Eva Thomas, et al.
Cancer
|
October 21, 2006
Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial
Corinne Veyret, Christelle Levy, Philippe Chollet, et al.
Oncology
|
December 5, 2014
Neurotoxicity as a prognostic factor in patients with metastatic breast cancer treated with ixabepilone as a first-line therapy
Xavier Durando, Florence Dalenc, Catherine Abrial, et al.
Page
of 2